No abstract

The study confirms encouraging results as well as good bone ingrowth of the cementless short stem arthroplasty METHA(®) even in patients with osteonecrosis.

III.

A number of short stems for total hip arthroplasty have been introduced during the last decade. We describe our experience with the NANOS prosthesis (Smith and Nephew, Marl, Germany). The potential increase of bone mass around a femoral short stem using bone densitometry may be an indicator for secondary ingrowth. We report the outcome of 72 NANOS short stems in 65 patients between March 2003 and October 2007. The mean follow-up was 5.2±0.7 years and the mean age of the patients was 63±8.3 years. Along with demographic data and co-morbidities, the Harris Hip Score, the Merle d'Aubigné mobility score, and a patient-centred questionnaire were evaluated pre-operatively and during follow-up. The Mean Harris Hip Score increased from 47.3±12.2 pre-operatively to 97.6±0.6 at the final follow-up. The Merle d'Aubigné mobility score increased from 7.6±1.4 pre-operatively to 11.8±0.3 at the final follow-up. None of the 72 stems were revised, providing a survival rate of 100%. Radiolucent lines were visible rasiographically in two patients during follow-up. The NANOS short stem demonstrated a satisfactory outcome at mid term follow-up. The clinical and radiological results support to the principle of metaphyseal anchorage of a short stem prosthesis. Long term evaluation will be of interest to determine if these encouraging trends are reflected by prolonged survivorship.

Injection of human BMSC in a fibrin glue matrix appears to lead to more mature tissue formation with more regular patterns of cell distribution. Advantages of this "in-vivo" tissue engineering approach are a homogenous cell-matrix mixture in a well-known and approved biological matrix, and simple, minimally-invasive application by injection.

Following injury, ligaments and tendons do not regain their normal biological and biomechanical status. This study analyzed whether an injection of human bone marrow stromal cells (BMSC) or human fibroblast in a liquid fibrin matrix influences the histological results, ultrastructural morphology, mRNA expression of essential extracellular matrix proteins, and material properties of the healing tissue. Standardized full-thickness, full-length defects of the central portion of patellar tendons were created in 96 immunodeficient rats, and filled with human BMSC in a fibrin matrix (BMSC group), human fibroblasts in a fibrin matrix (fibroblast group), or fibrin matrix only (matrix group), or left untreated (defect group). Histological sections revealed more mature tissue formation with more regular patterns of cell distribution in the BMSC group, without signs of ectopic tissue formation into bone or cartilage. Mean collagen fibril diameter and relative area covered by collagen fibrils were significantly higher at 10 and 20 days postoperatively in the BMSC group compared to the defect and matrix groups, and comparable to normal tendon tissue. Further, collagen I mRNA expression, collagen I/collagen III mRNA ratio, and Young's modulus were significantly increased at 20 days postoperatively in comparison to the defect and matrix groups. In the fibroblast group, only mean collagen fibril diameter was significantly higher compared to the defect group, whereas the other biological and biomechanical parameters were not significantly improved. This study reveals that an injection of BMSC in a liquid fibrin matrix stimulates histological, ultrastructural, molecular biologic, and biomechanical parameters of patellar tendon healing, whereas injection of fibroblasts in fibrin matrix had only minor effects on the stimulation of tendon healing.

Biomechanical testing showed higher pull-out forces for magnesium compared with a commercial polymer screw. Hence, they suggest better stability and are a potential alternative. The thread geometry does not significantly influence the stability provided by the magnesium implants. This study shows the first promising results of a degradable material, which may be a clinical alternative in the future.

The TightRope® fixation shows significantly lower initial displacement compared to the suture group. The TightRope® fixation might be an alternative for the repair of ACL tibial avulsion fractures that can be used arthroscopically.